Collyrium for the treatment of conial cornea with 'cross-linking' trans-epithelial technique

摘要

Collyrium for the treatment for patients suffering from conical cornea containing the riboflavin photosensitising substance and a surface-active agent to assist penetration of the collyrium in the corneal epithelium; compared with normal collyria for the treatment of conical cornea, the product according to the invention has the advantage of not requiring the removal of the corneal epithelium, with the absence of pain for the patient, who does not need particular post treatment therapy, no longer complains of edema due to the removal of the epithelium and preserves the original corneal transparency.